Delivery Order SPE2DB20D3505-SPE2DB20FT3A6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $2,753.63 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA and Amerisourcebergen, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $2,353.02, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver essential...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,127.30, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA that is valued at up to $999,999,999 and runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,265.02, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies. The contract, valued at $1,684.86, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,714.99 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which runs through November 2026. This single-award IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for a Delivery Order valued at $1,356.79 to provide a broad range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of a wide range of pharmaceutical products and medical supplies to support Defense Logistics Agency (DLA) Troop Support Medical. The $12,338.50 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA. This single-award IDC serves as the primary vehicle for the company to provide critical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,764.06 for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a broad range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,235.89, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver essential...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB20FT3A6Delivery Order
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a broad range of pharmaceutical products and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical. The $2,569.04 delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which runs through November 2026. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/16/20 |